| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |